Richard B Parsons Selected Research

Nicotinamide N-Methyltransferase

4/2021	High Expression of Nicotinamide N-Methyltransferase in Patients with Sporadic Alzheimer's Disease.
1/2021	Nicotinamide N-Methyltransferase: An Emerging Protagonist in Cancer Macro(r)evolution.
3/2020	Nicotinamide N-methyltransferase expression in SH-SY5Y human neuroblastoma cells decreases oxidative stress.
1/2020	Nicotinamide N-Methyltransferase: Genomic Connection to Disease.
1/2017	Nicotinamide N-Methyltransferase in Health and Cancer.
5/2011	The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors.
5/2003	High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson's disease.
2/2002	Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard B Parsons Research Topics

Disease

9	Parkinson Disease (Parkinson's Disease) 01/2022 - 02/2002
8	Neoplasms (Cancer) 01/2021 - 05/2011
7	Neuroblastoma 03/2020 - 05/2011
3	Alzheimer Disease (Alzheimer's Disease) 04/2021 - 10/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2021 - 06/2012
2	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2013
1	Synucleinopathies 01/2022
1	COVID-19 01/2021
1	Melanoma (Melanoma, Malignant) 09/2020
1	Frontotemporal Dementia (Semantic Dementia) 10/2018
1	TDP-43 Proteinopathies 10/2018
1	Drug Resistant Epilepsy 01/2018
1	Obesity 01/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2015
1	Breast Neoplasms (Breast Cancer) 04/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2012

Drug/Important Bio-Agent (IBA)

13	N-nitroso-N-methyltyramine (NNMT)IBA 04/2021 - 02/2002
8	Nicotinamide N-MethyltransferaseIBA 04/2021 - 02/2002
3	NAD (NADH)IBA 01/2022 - 05/2003
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
3	EnzymesIBA 01/2021 - 05/2003
3	Pharmaceutical PreparationsIBA 09/2020 - 05/2017
3	Adenosine Triphosphate (ATP)IBA 03/2020 - 05/2011
2	Cholinergic Agents (Cholinergics)IBA 11/2019 - 06/2012
2	Carbolines (Beta-Carbolines)IBA 10/2016 - 05/2003
1	SynucleinsIBA 01/2022
1	Nicotinamide MononucleotideIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Protein AggregatesIBA 10/2018
1	DipeptidesIBA 10/2018
1	CannabidiolIBA 01/2018
1	CannabinoidsIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2017
1	MethyltransferasesIBA 10/2016
1	pyridineIBA 10/2016
1	Morphine (MS Contin)FDA LinkGeneric 01/2016
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2016
1	SirtuinsIBA 11/2015
1	Neuroprotective AgentsIBA 08/2015
1	Clerodane DiterpenesIBA 04/2015
1	DiterpenesIBA 04/2015
1	fascinIBA 04/2015
1	crispene EIBA 04/2015
1	Mitochondrial DNA (mtDNA)IBA 06/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2006
1	TetrahydroisoquinolinesIBA 05/2003
1	Niacinamide (Nicotinamide)FDA LinkGeneric 05/2003

Therapy/Procedure

4	Therapeutics 01/2021 - 03/2013
1	Immunotherapy 09/2020
1	Radiotherapy 03/2013